There is significant evidence that cigarette smokers who reduce
their consumption have a lower risk of lung cancer and all-cause
mortality than those who do not, but reductions in risk of CVD
and smoking-related cancer associated with cutting down cigarette
consumption are not clearly demonstrated. Nor is an effect
of cutting down clearly established for COPD or on the rate of
FEV1 reduction.